Newswise — PHILADELPHIA—(May 4, 2016)—The Wistar Institute, an international biomedical research leader in cancer, immunology and infectious diseases, and Plumbline Life Sciences, Inc., an independent South Korean biotechnology company focused on animal health, are pleased to announce a partnership that leverages Wistar’s cutting-edge vaccine research and Plumbline’s expertise developing animal treatments and vaccines.
Cancer is not just a human disease. Animals are affected as well, with 50 percent of all pets dying from cancer-related complications each year. Pet owners are seeking therapeutic options for animals they have bonded with and consider part of the family. Now research advances are resulting in cancer and infectious disease treatments that were traditionally not an option for animals.
“We are excited to apply our research advances in vaccine development for humans to improve treatments against disease in companion animals,” said David Weiner, Ph.D., Wistar executive vice president, director of the Vaccine Center, and the W.W. Smith Charitable Trust Professorship for Cancer Research. “As our research progresses, we believe there is the potential to advance the science into a successful product.”
“David’s achievements in the development and creation of vaccines generates such potential for Plumbline’s efforts to reduce animal disease and death,” said Kyoon Andrew Kim, CFO of Plumbline Life Sciences, Inc. “We look forward to building a strong partnership and saving animal lives though the development of promising vaccines.”
“We are pleased to be working with Plumbline,” said Heather A. Steinman, Ph.D., MBA, Wistar’s vice president for Business Development and executive director of Technology Transfer. “Partnerships with good people and enterprises are fundamental to accelerating the pace of moving Wistar discoveries from ‘bench to bedside’ and we take the long-term view on how our research—and the right partnerships—can make a positive societal impact through better treatments and breakthrough therapies for people and animals alike.”
Plumbline Life Sciences, Inc., is an independent animal health company that utilizes innovative DNA therapy platform technologies and is based in Seoul, South Korea. Led by an experienced team of biotechnology scientists and managers from the U.S. and Korea, Plumbline Life Sciences, Inc., develops therapeutics and other products for animals such as dogs, cats and horses. www.plumblinels.comThe Wistar Institute is an international leader in biomedical research with special expertise in cancer research and vaccine development. Founded in 1892 as the first independent nonprofit biomedical research institute in the country, Wistar has held the prestigious Cancer Center designation from the National Cancer Institute since 1972. The Institute works actively to ensure that research advances move from the laboratory to the clinic as quickly as possible. Wistar’s Business Development team is dedicated to advancing Wistar Science and Technology Development through creative partnerships. www.wistar.org.
RSS